BioCentury | Dec 31, 2020
Management Tracks

Biden-Harris team picks coordinators for COVID-19 task force; plus moves at Taysha, Alligator and ImmunityBio

...deputy administrator of FEMA, will be supply coordinator; Bechara Choucair, SVP and chief health officer for Kaiser Permanente...
BioCentury | Jun 17, 2020
Emerging Company Profile

Lightspeed, Klausner back Stanford cell therapy spinout Orca in new $192M round

...series D investors included 8VC, DCVC Bio, ND Capital, Mubadala Investment Co., Kaiser Foundation Hospitals, Kaiser Permanente...
...Investors: Lightspeed Venture Partners, 8VC, DCVC Bio, ND Capital, Mubadala Investment Co., Kaiser Foundation Hospitals, Kaiser Permanente...
BioCentury | Feb 26, 2020
Product Development

U.S. testing of coronavirus vaccine, therapeutic begin

...trial, which will enroll 45 healthy volunteers to receive mRNA-1273, is being conducted at the Kaiser Permanente...
BioCentury | Dec 7, 2019
Product Development

U.S. biosimilars glass--half full or half empty?

...a biologic, that isn’t the case across the U.S. healthcare sector. Integrated care systems like Kaiser Permanente...
...that are on the original biologic’s label, Amy Gutierrez, SVP and chief pharmacy officer for Kaiser Permanente...
...Avakine (Former), infliximab (Generic), Remicade (Other) Novartis AG Amgen Inc. Samsung Bioepis Co. Ltd. Mylan N.V. Sandoz IQVia Holdings Inc. Coherus BioSciences Inc. Kaiser Permanente...
BioCentury | Nov 2, 2019
Finance

American Cancer Society’s BrightEdge venture fund hoping to do well by doing good

...Advisors, funds and accounts advised by T. Rowe Price Associates Inc., Roche Venture Fund and Kaiser Permanente...
BioCentury | Jul 24, 2019
Financial News

New investors bring key connections to Freenome’s machine learning diagnostics

...Partners; also investing for the first time were Perceptive Advisors, affiliates of T. Rowe Price, Kaiser Permanente...
...behind each one” of the new investors’ inclusion, Otte told BioCentury. For example, he said Kaiser Permanente...
BioCentury | Jun 13, 2019
Financial News

June 13 Financial Quick Takes: Hansoh prices $1B HKEX IPO; plus Provention, Genome Medical, InGeneron and more

...and Dreamers Fund also participated, as did existing investors Canaan Partners, GE Ventures, Illumina Ventures, Kaiser Permanente...
BioCentury | Nov 6, 2018
Politics & Policy

FDA releases real-world data collection app

...Commissioner Scott Gottlieb said. The release follows completion of a pilot study that FDA and Kaiser Permanente...
BioCentury | Nov 5, 2018
Politics & Policy

Patient, consumer groups push back on biologics exclusivity

...AHIP), American College of Physicians, Association for Accessible Medicines, Blue Cross and Blue Shield Association, Kaiser Permanente...
BioCentury | Nov 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2018

...transcription factor 1 (SIM1) A SNP on SIM1 could help predict the risk of ED Kaiser Permanente...
Items per page:
1 - 10 of 110
BioCentury | Dec 31, 2020
Management Tracks

Biden-Harris team picks coordinators for COVID-19 task force; plus moves at Taysha, Alligator and ImmunityBio

...deputy administrator of FEMA, will be supply coordinator; Bechara Choucair, SVP and chief health officer for Kaiser Permanente...
BioCentury | Jun 17, 2020
Emerging Company Profile

Lightspeed, Klausner back Stanford cell therapy spinout Orca in new $192M round

...series D investors included 8VC, DCVC Bio, ND Capital, Mubadala Investment Co., Kaiser Foundation Hospitals, Kaiser Permanente...
...Investors: Lightspeed Venture Partners, 8VC, DCVC Bio, ND Capital, Mubadala Investment Co., Kaiser Foundation Hospitals, Kaiser Permanente...
BioCentury | Feb 26, 2020
Product Development

U.S. testing of coronavirus vaccine, therapeutic begin

...trial, which will enroll 45 healthy volunteers to receive mRNA-1273, is being conducted at the Kaiser Permanente...
BioCentury | Dec 7, 2019
Product Development

U.S. biosimilars glass--half full or half empty?

...a biologic, that isn’t the case across the U.S. healthcare sector. Integrated care systems like Kaiser Permanente...
...that are on the original biologic’s label, Amy Gutierrez, SVP and chief pharmacy officer for Kaiser Permanente...
...Avakine (Former), infliximab (Generic), Remicade (Other) Novartis AG Amgen Inc. Samsung Bioepis Co. Ltd. Mylan N.V. Sandoz IQVia Holdings Inc. Coherus BioSciences Inc. Kaiser Permanente...
BioCentury | Nov 2, 2019
Finance

American Cancer Society’s BrightEdge venture fund hoping to do well by doing good

...Advisors, funds and accounts advised by T. Rowe Price Associates Inc., Roche Venture Fund and Kaiser Permanente...
BioCentury | Jul 24, 2019
Financial News

New investors bring key connections to Freenome’s machine learning diagnostics

...Partners; also investing for the first time were Perceptive Advisors, affiliates of T. Rowe Price, Kaiser Permanente...
...behind each one” of the new investors’ inclusion, Otte told BioCentury. For example, he said Kaiser Permanente...
BioCentury | Jun 13, 2019
Financial News

June 13 Financial Quick Takes: Hansoh prices $1B HKEX IPO; plus Provention, Genome Medical, InGeneron and more

...and Dreamers Fund also participated, as did existing investors Canaan Partners, GE Ventures, Illumina Ventures, Kaiser Permanente...
BioCentury | Nov 6, 2018
Politics & Policy

FDA releases real-world data collection app

...Commissioner Scott Gottlieb said. The release follows completion of a pilot study that FDA and Kaiser Permanente...
BioCentury | Nov 5, 2018
Politics & Policy

Patient, consumer groups push back on biologics exclusivity

...AHIP), American College of Physicians, Association for Accessible Medicines, Blue Cross and Blue Shield Association, Kaiser Permanente...
BioCentury | Nov 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2018

...transcription factor 1 (SIM1) A SNP on SIM1 could help predict the risk of ED Kaiser Permanente...
Items per page:
1 - 10 of 110